靶向可治疗特征治疗重度哮喘:一项随机对照试验
该研究对140例重度哮喘患者进行多维评估以刻画可治疗特征,其中55例纳入16周平行组随机对照试验,比较靶向预设可治疗特征的管理与常规护理。结果显示靶向治疗可行,并显著改善健康相关生活质量(0.86单位,p<0.001)和哮喘控制(0.73,p=0.01)。
要点
- 重度哮喘患者平均每人存在10.44±3.03个可治疗特征。
- 靶向可治疗特征的个体化治疗可显著改善生活质量与哮喘控制。
- 多维评估有助于识别重度哮喘的可治疗特征负担。
核心结论
- 多维评估可检测重度哮喘的可治疗特征并识别显著的特征负担。
- 靶向可治疗特征的个体化医疗方法可改善健康相关生活质量和哮喘控制,并减少基层急性就诊。
研究设计与样本
- 横断面研究纳入140例重度哮喘患者进行多维评估以刻画可治疗特征。
- 符合条件的55例重度哮喘患者参与16周平行组随机对照试验,比较靶向预设可治疗特征的管理与重度哮喘门诊常规护理。
- 试验主要终点为患者报告的健康相关生活质量。
主要发现
- 重度哮喘患者平均每人有10.44±3.03个特征,包括3.01±1.54个肺部特征、4.85±1.86个肺外特征和2.58±1.31个行为/危险因素。
- 靶向特征的个体化治疗可行,并显著改善健康相关生活质量(0.86单位,p<0.001)。
- 靶向特征的个体化治疗显著改善哮喘控制(0.73,p=0.01)。
临床怎么用
- 对重度哮喘患者进行多维评估以识别可治疗特征。
- 根据识别出的可治疗特征制定个体化靶向治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Treatable traits have been proposed as a new paradigm for airway disease management. OBJECTIVES: To characterise treatable traits in a severe asthma population and to determine the efficacy of targeting treatments to these treatable traits in severe asthma. METHODS: Participants (n=140) with severe asthma were recruited to a cross-sectional study and underwent a multidimensional assessment to characterise treatable traits. Eligible participants with severe asthma (n=55) participated in a 16-week parallel-group randomised controlled trial to determine the feasibility and efficacy of management targeted to predefined treatable traits, compared to usual care in a severe asthma clinic. The patient-reported outcome of health-related quality of life was the trial's primary end-point. MAIN RESULTS: Participants with severe asthma had a mean±sd of 10.44±3.03 traits per person, comprising 3.01±1.54 pulmonary and 4.85±1.86 extrapulmonary traits and 2.58±1.31 behavioural/risk factors. Individualised treatment that targeted the traits was feasible and led to significantly improved health-related quality of life (0.86 units, p<0.001) and asthma control (0.73, p=0.01). CONCLUSIONS: Multidimensional assessment enables detection of treatable traits and identifies a significant trait burden in severe asthma. Targeting these treatable traits using a personalised-medicine approach in severe asthma leads to improvements in health-related quality of life, asthma control and reduced primary care acute visits. Treatable traits may be an effective way to address the complexity of severe asthma.
引用
- McDonald VM, Clark VL, Cordova-Rivera L, et al. Targeting treatable traits in severe asthma: a randomised controlled trial. Eur Respir J. 2020. PMID: 31806719. doi:10.1183/13993003.01509-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。